Red light vs blue light: what each does for your skin

Red light and blue light are often sold in the same mask, but they do fundamentally different things to your skin: red and near-infrared target the signs of ageing, while blue targets the bacteria behind acne — and the evidence behind each is not equally strong.

#The short version

Red (roughly 630–660 nm) and near-infrared (around 830 nm) light are used for skin ageing: fine lines, roughness and collagen. Blue light (around 415 nm) is used for mild-to-moderate acne. They reach different targets in the skin, work through different biology, and suit different concerns. If your main goal is smoother, firmer-looking skin over time, red and near-infrared are the relevant colours. If it is spots, blue is the one with an acne-specific mechanism — though, as we explain below, the independent evidence for blue is weaker than the marketing tends to suggest.

#Two colours, two mechanisms

The reason you cannot swap one colour for another is that they are absorbed by different molecules and act on different targets. This is worth understanding before you buy, because it explains what each setting can — and cannot — realistically do.

Red and near-infrared: energising the mitochondria

The leading explanation is photobiomodulation. Red and near-infrared light is absorbed by cytochrome c oxidase, an enzyme in the mitochondria, which appears to nudge up cellular energy (ATP) and generate a small burst of reactive oxygen species that acts as a signal (Avci et al., 2013; Barolet, 2008). In laboratory and animal work this can stimulate fibroblasts to produce more collagen and can calm inflammation. Longer near-infrared wavelengths penetrate deeper than visible red, which is why 830 nm is often paired with 630–660 nm. Two caveats matter: much of the mechanistic detail comes from in-vitro and animal studies rather than living human skin, and the response is biphasic (Huang et al., 2009) — too little does nothing, a moderate dose helps, and more is not better.

Blue: a bacterial target

Blue light works through an entirely different route. At around 415 nm it is absorbed by porphyrins — pigments produced by Cutibacterium acnes, the bacterium involved in acne. That absorption generates singlet oxygen inside the bacteria, which is bactericidal (Ablon, 2018). Blue does not meaningfully reach the deeper dermis and has no direct collagen-building rationale; its case is specifically antibacterial and anti-inflammatory for acne, not anti-ageing.

#Wavelength, concern and evidence at a glance

#Red and near-infrared for ageing: modest but real

For facial ageing, the honest summary is that red and near-infrared produce modest, gradual improvements — not a transformation. In a split-face randomised trial, 830 nm and 633 nm treatment reduced wrinkles by up to around 36% and improved elasticity, with histology showing more collagen (Lee et al., 2007). A later controlled trial reported significantly greater collagen density and roughly a 70% improvement in wrinkle status versus controls (Wunsch & Matuschka, 2014) — though that study was funded by the device maker and its control group unusually worsened, so we treat the headline figure with caution. A systematic review of 31 randomised trials placed the strongest support around wound healing and acne, rated skin rejuvenation lower, and judged the overall evidence quality limited while noting the treatments are low-risk (Jagdeo et al., 2018).

The practical takeaways: results build over roughly 8–12 weeks of consistent use, at-home irradiance is lower than a clinic's, and getting the irradiance and dose right matters more than lengthening a single session. For whether the underlying effect holds up at all, see does LED light therapy work?

#Blue for acne: promising trials, weak overall evidence

Individual blue-light trials can look impressive. A double-blind randomised trial of combined blue-red light reported around a 77% drop in inflammatory lesions over 12 weeks (Kwon et al., 2013) — but with only 35 participants. When independent researchers pool the trials, the picture is far more cautious. A systematic review and meta-analysis of 14 randomised trials in nearly 700 people concluded the evidence is weak, the trials small and short, and the risk of bias high, with pooled effects often not statistically significant (Scott et al., 2019). An abridged Cochrane review reached a similar verdict: low-certainty evidence and no firm conclusions on the best light or dose (Barbaric et al., 2018). Blue light is a reasonable, low-risk adjunct for mild-to-moderate acne, but it should not be presented as a proven or standalone treatment.

#Can you combine red and blue?

Yes — and many masks offer both, either together or as separate modes. The rationale is straightforward: blue targets the bacterial and inflammatory side of acne while red helps calm inflammation and support healing, which is why several acne studies use a combined blue-red protocol (Kwon et al., 2013; Ablon, 2018). If your only concern is spots, blue-dominant or combined settings are the relevant ones; if it is ageing, red and near-infrared are what matter. There is little reason to expect blue to smooth wrinkles or red to clear a breakout on its own. When you are choosing a device that does both well, our how to choose an LED face mask guide and our pick of the best LED face masks walk through what actually matters.

#Safety and when blue is best avoided

LED masks in this range are generally well tolerated, and the reviews above consistently describe the risk as low (Jagdeo et al., 2018). A few sensible caveats apply:

• Rosacea and easily-flushed skin: blue light is best approached with caution, as light and warmth can sometimes aggravate redness. If you have rosacea, prioritise red and speak to a dermatologist before starting.
• Eyes: use the supplied eye protection. Bright blue light in particular is worth shielding your eyes from.
• Photosensitivity: if you take photosensitising medication (for example some antibiotics, oral retinoids or St John's Wort) or have a light-triggered condition, check with a clinician first.
• Consistency over intensity: because the dose response is biphasic (Huang et al., 2009), longer or more frequent sessions are not automatically better and can be counter-productive.